Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;42(8):1298-1309.
doi: 10.1002/jat.4270. Epub 2021 Dec 6.

The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS)

Megan E Solan  1 , Ramon Lavado  1
Affiliations
Review

The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS)

Megan E Solan et al. J Appl Toxicol. 2022 Aug.

Abstract

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a large class of industrial chemicals with a ubiquitous and persistent presence in the environment. Of the thousands of PFAS used by consumers and industry, very few have been thoroughly characterized for potential adverse effects. This is especially true for the novel short-chain (C < 8) alternatives that replaced legacy PFAS. Perfluoroalkyl and polyfluoroalkyl substances have revealed inconsistencies in the toxicokinetics predicted by animal models and empirical findings in humans. To adequately assess the possible health effects of short-chain PFAS, there is a need for robust aggregated data sets on the mechanistic underpinnings and physiochemical properties of these alternatives. Acquiring relevant data on the health effects of short-chain PFAS can be achieved through high-throughput methods supported by in vitro human cell-based models. This review briefly summarizes some of the toxicity data obtained using human cells in vitro, discusses the advantages and limitations of cell-based models, and provides insights on potential solutions to challenges presented with the use of these methods for use in safety assessments.

Keywords: cell-based assays; human toxicity; in vitro methods; risk assessment; short-chain PFAS.

PubMed Disclaimer

References

REFERENCES

    1. Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., Serrrano, J. A., Tietge, J. E., & Villeneuve, D. L. (2010). Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environmental Toxicology and Chemistry, 29(3), 730-741. https://doi.org/10.1002/etc.34
    1. Arbuckle, T. E., Kubwabo, C., Walker, M., Davis, K., Lalonde, K., Kosarac, I., Wen, S. W., & Arnold, D. L. (2013). Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. International Journal of Hygiene and Environmental Health, 216(2), 184-194. https://doi.org/10.1016/j.ijheh.2012.03.004
    1. ASTSWMO. (2015). Perfluorinated chemicals (PFCS): Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) information paper.
    1. Bangma, J., Szilagyi, J., Blake, B. E., Plazas, C., Kepper, S., Fenton, S. E., & Fry, R. (2020). An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environmental Toxicology, 35(12), 1395-1405. https://doi.org/10.1002/tox.23004
    1. Behr, A. C., Lichtenstein, D., Braeuning, A., Lampen, A., & Buhrke, T. (2018). Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro. Toxicology Letters, 291, 51-60. https://doi.org/10.1016/j.toxlet.2018.03.029

Publication types

Grants and funding

LinkOut - more resources